Group 1 - The company has revised its internal control systems to enhance governance and compliance with updated laws and regulations [1][2] - The revisions include renaming and merging several existing policies, such as the "Insider Information Management System" and the "Management System for Shareholders and Directors' Shareholdings" [1] - The updated internal control systems were disclosed on the Shanghai Stock Exchange website on the same day [2] Group 2 - The company appointed Mr. Yuan Xianming as the new Deputy General Manager, effective from the date of the board meeting [3][4] - Mr. Yuan has a background in management and has held various positions within the company, including General Manager of Zhejiang Jianfeng Pharmaceutical Co., Ltd. [5] - The appointment was approved by the board following a nomination process [4][22] Group 3 - The company held its second extraordinary general meeting of 2025 on November 21, where several resolutions were passed, including the cancellation of the supervisory board [6][7] - The meeting was conducted in compliance with legal and regulatory requirements, with all board members present [8][9] - The resolutions included amendments to the company's articles of association and the establishment of new governance structures [9][10] Group 4 - The company announced the resignation of Mr. Zhang Fengliang from the board, who will continue to serve in other capacities [26][28] - Following his resignation, Mr. Zhang was elected as the employee representative director at the same meeting [26][29] - The board composition remains compliant with legal requirements, ensuring operational continuity [28][30]
浙江尖峰集团股份有限公司 关于修订公司部分内控制度的公告